James Rucker

Has grant

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

A Feasibility RCT of Single-Dose Psilocybin in Unipolar Depressive Disorder Resistant to Standard Treatments

Open Date: 2018-03-01

Close Date: 2023-02-28

Grant: Close

Whole Genome Analysis of Copy Number Variation in a Large Case Control Study of Recurrent Depression.

Open Date: 2009-04-06

Close Date: 2012-04-05

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (11)

Simon Erridge

University College London

UNITED KINGDOM

View details

Will Lawn

King’s College London

UNITED KINGDOM

View details

Jason Ferris

Professor/Head of Global Substance Use and Mental Health

University of Queensland

AUSTRALIA

View details

Kim Kuypers

Associate Professor

University of Maastricht

NETHERLANDS

View details

Edward Jacobs

University of Oxford

UNITED KINGDOM

View details

Anya Borissova

King's College School

UNITED KINGDOM

View details

Sandrine Thuret

King’s College London

UNITED KINGDOM

View details

Anthony Vernon

King’s College London

UNITED KINGDOM

View details

Adam R Winstock

University College London

UNITED KINGDOM

View details

Victoria Williamson

King’s College London

UNITED KINGDOM

View details

Luke Jelen

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Rucker

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (19)

Psilocybin for dementia prevention?

UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: A cross-sectional study

A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials

Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants

Clinical outcome analysis of patients with multiple sclerosis - Analysis from the UK Medical Cannabis Registry

Assessment of Clinical Outcomes in Patients With Osteoarthritis

A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance

UK Medical Cannabis Registry

UK Medical Cannabis Registry

The development of psilocybin therapy for treatment-resistant depression: an update

Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom

On Redescribing the Indescribable: Trauma, Psychoanalysis and Psychedelic Therapy

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020

Evidence versus expectancy: the development of psilocybin therapy

Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry

RE: Proposed Assisted Dying Bill: implications for mental healthcare and psychiatrists

Psychedelic therapy for depressive symptoms

Psilocybin therapy for depression. A good trip?

Expectancy in placebo-controlled trials of psychedelics: if so, so what?

Collaborators (11)

Simon Erridge

Will Lawn

Jason Ferris

Kim Kuypers

Edward Jacobs

Anya Borissova

Sandrine Thuret

Anthony Vernon

Adam R Winstock

Victoria Williamson

Luke Jelen

Make your next move.